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Cluster of Lyme Disease Cases at a Summer Camp
in Kent County, Maryland
Lyme disease is the second most prevalent
emerging infectious disease in the United States;
more than 65,000 cases have been reported to the
Centers for Disease Control and Prevention since
the disease was first described by Steere and col-
leagues in 1977 (1).
In July 1994, a physician in Chestertown,
Maryland, reported eight cases of Lyme disease to
the Kent County Health Department. Five were
from a summer camp 10 miles north of Rock Hall
on the Chesapeake Bay. In one case-patient, a
9-year-old camper from Pennsylvania, erythema
migrans (EM) rash and left facial nerve palsy
developed the day after she arrived at the camp.
To determine whether Lyme disease was pre-
sent at the camp, we interviewed the eight coun-
selors who had EM or febrile illnesses during July
and 43 of the remaining 91 camp employees. Clus-
ters of cases of Lyme disease with a short and
specific exposure period (i.e., 10–12 weeks for the
100 counselors and 2–4 weeks for the 1,600 camp-
ers) had not been investigated in recent years.
All 51 surveyed camp employees gave histories
of tick exposure throughout the summer. Four
counselors had EM of 5 cm in diameter without
other symptoms or signs and were treated with
amoxicillin by the camp physician. Four other
counselors had recurrent fever of 102°F to 104°F,
severe headaches, somnolence, malaise, fatigue,
myalgia, and anorexia. All four described exten-
sive fatigue, drowsiness, and difficulty in getting
out of bed. Three described shaking chills, and one
had watery diarrhea. The camp physician admit-
ted them all to the camp dispensary; Lyme disease
was not diagnosed in any of them; only the patient
with diarrhea was given an antimicrobial agent,
trimethoprim/sulfamethoxazole. All patients im-
proved in 3 to 5 days.
Sera were obtained in mid-August from the 51
employees; for the eight patients described above,
this was 4 to 7 weeks after the onset of illness. All
sera were nonreactive in indirect fluorescence an-
tibody (IFA) tests against antigens for Rickettsia
rickettsii and Ehrlichia equi (used to screen for
human granulocytic ehrlichiosis). One patient,
who had an EM-like rash but no other symptoms,
had an IFA titer of 512 for E. chaffeensis (used to
screen for human monocytic ehrlichiosis).
Serologic testing for Borrelia burgdorferi by en-
zyme immunoassay (EIA) (Lyme Stat,
BioWhittker, Walkersville, Maryland) identified
patients with positive or borderline results (Table 1).
Hard ticks were collected by dragging felt ma-
terial at several sites within the camp on three
occasions during August. Collected adult Ixodes
scapularis were tested by an antigen capture EIA
for outer surface protein A (2). Ten (16.9%) of 59
male ticks were positive for B. burgdorferi. Al-
though the infection rate was higher in female
ticks collected from the camp, the results cannot
be interpreted because the female ticks were co-
fed on rabbits; it is not certain whether this could
cross-infect ticks feeding on the same animals.
We considered exposure to B. burgdorferi in this
camp to be high (suspected acute Lyme disease-
like illness incidence of 6% to 8%). The incidence
rate depends on whether patients 6 and 7, who had
flulike illnesses and positive EIAs and negative
Western blot results (Marblot Strip Test System,
Mardex Diagnostics, Carlsbad, California) are
Table. Results of WB antibody tests for Borrelia burgdorferi in
summer camp residents with positive (titer ³ 1.00) and bor-
derline (titer = 0.80–0.99) EIA results
Serology
    WB
Subject Syndrome EIA IgM IgG
1 EM 1.82 Pos Pos
2 EM 1.40 Neg Pos
3 EM 1.21 Neg Neg
4 EM 3.21 Pos Pos
5 Flulike 1.00 Neg Pos
6 Flulike 1.04 Neg Neg
7 Flulike 1.80 Neg Neg
8 Flulike 2.46 Neg Pos
9 None 0.96 Neg Neg
10 None 0.96 ND Pos
11 None 1.82 Neg Pos
12 None 2.21 Neg Neg
13 Sinusitis 1.11 Pos Neg
14 Sinusitis 0.93 Neg Neg
15 None 1.00 Neg Neg
16 Rocky Mountain 1.14 Neg Neg
 spotted  fever,
 1991
EIA = enzyme immunoassay; EM = erythema migrans; ND = no data; WB =
Western blot.
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assuming that the 49 unexamined counselors did
not have Lyme disease. Also, Kent County has one
of the highest incidences of Lyme disease in the
state (3), many deer were present in the woods and
fields in and around the camp, and all counselors
reported frequent exposure to ticks.
The four patients who had an acute febrile
illness without cutaneous lesions were not in-
itially suspected to have acute Lyme disease. We
believe that flulike illness without EM is a more
common manifestation of acute Lyme disease than
is generally appreciated since, as in patients 5
through 8 (Table), Lyme disease is often not con-
sidered in the differential diagnosis (4). Acutely
febrile patients, who have been  bitten by a tick in
Lyme disease-endemic areas also should be con-
sidered for early antibiotic therapy. Doxycycline or
another tetracycline is effective for Lyme disease
as well as for infections with E. chaffeensis and R.
rickettsii, which are also transmitted by ticks and
may have a similar clinical syndrome (5). Serologic
testing, although it can confirm the diagnosis dur-
ing the convalescence phase, may not establish an
early diagnosis in either case, since antibody re-
sponses to all three infections are usually delayed
until 2 to 4 weeks after the onset of symptoms and
may not occur in patients treated with antibiotics
(5-8).
We interpreted the Western blots according to
criteria proposed at the Second National Meeting
on Serological Diagnosis of Lyme disease (6). Of
the four patients with EM and with EIAs positive
for B. burgdorferi, patient 3, who had antibodies
to E. chaffeensis, did not have IgG and/or IgM
evidence of B. burgdorferi infection by Western
blot. He also had no symptoms compatible with
monocytic ehrlichiosis. Two (patients 6 and 7) of
the four with flulike illnesses and with EIAs posi-
tive for B. burgdorferi did not have B. burgdorferi
infection confirmed by Western blot. Positive or
borderline serologic results for B. burgdorferi
infection in patients 9 through 16 (Table) who did
not have a clinical history compatible with Lyme
disease could have been caused by asymptomatic
infection, antibody responses from prior infec-
tions, cross-reactions from other infections, or
false-positive reactions (8). Many of the counselors
had been at the camp during previous summers
and could have had prior mild, nondiagnosed in-
fections with B. burgdorferi. Another possibility is
that the EIA titers in some of the patients were
high normal values, which may have been the case
for patients 9, 14, 15, and 16. Patient 13 who had
IgM evidence of recent infection on Western blot
may have had a mild infection with B. burgdorferi
during the previous month. However, this is im-
possible to confirm without acute-phase and con-
valescent-phase (or preexposure and post-
exposure) serum samples. This is also pertinent to
those with flulike symptoms and negative West-
ern blot results (patients 6 and 7).
The usefulness of using EIA screening and
Western blot confirmation in seroepidemiologic
studies for Lyme disease has not been established.
The positive predictive value of a diagnostic test
is highly dependent on the prevalence of the dis-
ease being studied. If the prevalence of Lyme
disease in the population screened is very low, the
positive predictive value of testing may be too low
to be diagnostically useful.
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